Chronic care · Diabetes
Diabetes monitoring between appointments
Diabetes is managed daily but reviewed occasionally. Continuous glucose monitors already produce a rich picture of the days in between — Rasd carries that picture, and the other signals around it, to the care team the patient chooses.
Why diabetes is where continuous data helps most
Few conditions generate as much day-to-day data as diabetes, and few are reviewed as infrequently relative to how much they change. A person may see their clinician two or three times a year, while their readings move every day. That gap is where a gradual drift goes unseen. Following the trend continuously does not replace clinical judgement — it gives the clinician a fuller record to apply it to.
What a continuous glucose monitor adds
A CGM reports throughout the day rather than at isolated moments, which turns scattered numbers into a shape: how readings respond to meals, sleep, activity and stress. Rasd reads that stream alongside the rest of a person's signals and looks for movement away from their own established pattern. The comparison is always against the individual's baseline, not a population average.
The signals around glucose
Diabetes rarely travels alone. Blood pressure, resting heart rate, weight and oxygen saturation all form part of how the condition is followed over time, and each is measured by a device many people already own. Because Rasd is neutral toward hardware, a glucose monitor, a blood-pressure cuff, a smart scale and a smartwatch can all contribute to one record instead of four disconnected apps.
What the care team receives
When a pattern appears that deserves review, the patient is notified in plain language and decides who to share it with. The provider receives the relevant trend and a summary of what changed, so the conversation starts from evidence rather than recall. Nothing reaches a provider until the patient consents, and access can be withdrawn at any time.
What Rasd does not do
Rasd does not diagnose, does not stage a condition, does not predict complications and does not recommend treatment or medication. It reports that a measured signal has moved away from a person's own normal and suggests the type of specialist who could review it. Every clinical decision remains with a qualified professional.
What continuous diabetes monitoring changes
- The days between appointments stop being invisible
- Glucose is read alongside blood pressure, weight and heart signals
- Comparison is against the person's own baseline, not an average
- The patient decides which provider sees the trend
- Alerts describe an observation and suggest a specialty — never a diagnosis
Common questions
- Does Rasd replace my glucose monitor or my doctor?
- Neither. Rasd reads from the device you already use and carries the trend to the clinician you choose. It does not measure anything itself and does not make clinical decisions.
- Can Rasd tell me if my diabetes is getting worse?
- No. Rasd can tell you that a reading has moved away from your usual pattern and suggest you review it with an appropriate specialist. Interpreting what that means is a clinician's role.
- Which glucose devices work with Rasd?
- Rasd is designed to be neutral toward the manufacturer, so continuous glucose monitors can feed the same record as blood-pressure monitors, smart scales and smartwatches.
- Does my insurer see my glucose readings?
- Only if you choose to share with them. Sharing is per-provider and consent-based, and you can withdraw access at any time.
Supporting people managing diabetes
Insurers, hospitals and clinics — tell us about your organisation and our team will reach out.
Request a demoRasd provides health awareness and guidance only. It does not diagnose, treat, or replace professional medical advice. Always consult a qualified healthcare provider.